<b>Conclusions</b>: This finding newly suggests that SNAT1 may function as a sensor or receptor ("transceptor") for glutamine rather than being a direct and primary glutamine transporter, and could open up new therapeutic options targeting melanoma cells. The gene discussed is SLC38A1; the disease is melanoma.